Rezultaty - Kwok, Kenneth
- Rezultaty 1 - 20 Rezultaty od 28
- Idź do następnej strony
-
1
A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus od Dombi, Theresa, Kwok, Kenneth K, Sultan, Marla B
Wydane 2012Text -
2
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis od Fleischmann, Roy, Strand, Vibeke, Wilkinson, Bethanie, Kwok, Kenneth, Bananis, Eustratios
Wydane 2016Text -
3
-
4
-
5
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib od Bird, Paul, Hall, Stephen, Nash, Peter, Connell, Carol A, Kwok, Kenneth, Witcombe, David, Thirunavukkarasu, Krishan
Wydane 2019Text -
6
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi... od Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F
Wydane 2017Text -
7
Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test od Lim, Julian, Ebstein, Richard, Tse, Chun-Yu, Monakhov, Mikhail, Lai, Poh San, Dinges, David F., Kwok, Kenneth
Wydane 2012Text -
8
Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized con... od Li, Zhanguo, An, Yuan, Su, Houheng, Li, Xiangpei, Xu, Jianhua, Zheng, Yi, Li, Guiye, Kwok, Kenneth, Wang, Lisy, Wu, Qizhe
Wydane 2018Text -
9
Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis od Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.
Wydane 2021Text -
10
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population od Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan
Wydane 2018Text -
11
Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies od van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley
Wydane 2020Text -
12
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials od Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Wydane 2020Text -
13
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials od Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Wydane 2020Text -
14
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme od Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard
Wydane 2016Text -
15
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs od Charles-Schoeman, Christina, Burmester, Gerd, Nash, Peter, Zerbini, Cristiano A F, Soma, Koshika, Kwok, Kenneth, Hendrikx, Thijs, Bananis, Eustratios, Fleischmann, Roy
Wydane 2016Text -
16
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis od Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Wydane 2016Text -
17
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment od Winthrop, Kevin L., Curtis, Jeffrey R., Yamaoka, Kunihiro, Lee, Eun Bong, Hirose, Tomohiro, Rivas, Jose L., Kwok, Kenneth, Burmester, Gerd R.
Wydane 2021Text -
18
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se... od Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes
Wydane 2022Text -
19
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses od Strand, Vibeke, Kavanaugh, Arthur, Kivitz, Alan J., van der Heijde, Désirée, Kwok, Kenneth, Akylbekova, Ermeg, Soonasra, Arif, Snyder, Mark, Connell, Carol, Bananis, Eustratios, Smolen, Josef S.
Wydane 2018Text -
20
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management od Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R
Wydane 2020Text